For healthcare professionals. This information does not replace clinical judgement in the individual case; the current summary of product characteristics and the guidelines cited are authoritative.
Medically reviewed: Dr. med. univ. Daniel Pehböck, DESA, 01.11.2026
Ondansetron (Antiemetic (5-HT₃ antagonist)) – indications: PONV prophylaxis and treatment – adults, PONV prophylaxis and treatment – children from 1 month. Weight-based dosing in mg and ml in the app, with sources.
Indications
- PONV prophylaxis and treatment – adults
- PONV prophylaxis and treatment – children from 1 month
Complete in the app
Weight-based doses in mg and ml, preparations, contraindications and notes – in the app, also offline.
Sources and guidelines
- Gan TJ, Belani KG, Bergese S et al. Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting. Anesth Analg 2020;131:411–448.
- Summaries of product characteristics of authorised products – product and section for each dose in the app.